Yim Kyongwook, Nazeer Syed H, Kiska Deanna, Rose Frederick B, Brown Douglas, Cynamon Michael H
Division of Infectious Diseases, Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.
Scand J Infect Dis. 2004;36(2):150-4. doi: 10.1080/00365540310017474.
A case of recurrent Mycobacterium xenopi infection presenting as Pott's disease in a patient receiving etanercept for severe rheumatoid arthritis is described. A 49-y-old Caucasian male had received a total of 11 months of anti-mycobacterial therapy for hip infection acquired 15 months earlier; he presented with progressive back pain, which was diagnosed as Pott's disease. He had been treated with etanercept in addition to his prior immunosuppressive agents after the diagnosis of hip infection.
